Subscribe free

HPB & Spleen ·

Contrast-enhanced computed tomography can predict metastatic potential of small nonfunctioning pancreatic neuroendocrine tumors.

Tumor vascularity on contrast-enhanced computed tomography was studied for its predictive value in determining metastatic potential in small nonfunctioning pancreatic neuroendocrine tumors. The study included 77 patients who underwent pancreatectomy for nonfunctioning pancreatic neuroendocrine tumors, with a focus on small tumors (≤2.0 cm). The results showed that the computed tomography a/e ratio was a useful predictor of the metastatic potential of these tumors, specifically in relation to the degree of fibrosis and the presence of microscopic venous invasion. These findings can potentially guide decision-making regarding the observation of small tumors.

Journal Article by Kubo H, Ohgi K (…) Sugiura T et 6 al. in BMC Surg

Copyright © 2023 Elsevier Inc. All rights reserved.

read the whole article in BMC Surg

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

All papers in HPB & Spleen →